Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001)
Introduction
Non-fermentative Gram-negative bacilli (NFB) are primarily opportunists, mainly causing infections in seriously ill, hospitalised patients, immunocompromised hosts, and patients with cystic fibrosis. NFBs can be isolated from the environment, are intrinsically resistant to many commonly used antimicrobial agents and can cause indwelling device-related infections. Most of these organisms have the potential to spread horizontally on fomites or on the hands of medical personnel, and recent exposure to broad spectrum antimicrobial agents represents an important risk factor for acquisition of these organisms [1], [2], [3], [4].
Pseudomonas aeruginosa is a leading cause of nosocomial infection, especially among patient hospitalised in intensive care units [5], [6], [7]. This organism is the second most common cause of nosocomial pneumonia and the third most common cause of urinary tract infections in United States hospitals [8]. Acinetobacter spp. have also become an important cause of nosocomial infection, especially pneumonia, in the last years and the prevalence of Acinetobacter spp. infections shows intriguing regional and seasonal variations [1], [9], [10]. All other NFB are less frequently isolated, but the prevalence of infections caused by these pathogens has been constantly increasing [2], [3], [4]. In addition, susceptibility testing methodologies are not completely standardized for most of these organisms, especially routine tests used in clinical microbiology laboratories. Thus, the knowledge of their epidemiology and antimicrobial susceptibility patterns are necessary in order to allow the development of therapeutic strategies [11].
The objective of the present report was to establish the frequency of occurrence and the antimicrobial susceptibility of contemporary NFB species collected during the first 5 years (1997–2001) of the SENTRY Antimicrobial Surveillance Program worldwide.
Section snippets
Material and methods
The SENTRY Program monitored the predominant pathogens and antimicrobial resistance patterns of nosocomial and community-acquired infections via a broad network of sentinel hospitals in four major world regions: Asia-Pacific, Europe, Latin America, and the United States/Canada. The program was started in January 1997 and the primary monitored infections have been blood stream infections, outpatient respiratory tract infections due to specific fastidious organisms, pneumonia in hospitalised
Results
Table 1 shows the frequency of occurrence of various genus and species groups among the NFB. P. aeruginosa was the most frequently isolated pathogen (11 968 isolates; 64.5%), followed by Acinetobacter spp. (3468 isolates; 18.7%) and S. maltophilia (1488 isolates; 8.0%). These three pathogens accounted for more than 90% of the isolates processed. Any other pathogen accounted for ≤3% of the collection. The antimicrobial susceptibility patterns of P. aeruginosa, Acinetobacter spp. and S.
Discussion
Systemic infections due to NFB are usually difficult to treat because of relatively limited choice of effective antimicrobial agents. In addition, these pathogens frequently cause disease in severely debilitated or immunocompromised patients. Thus, mortality rates of NFB infections are generally high and the rapid introduction of appropriate empirical antimicrobial therapy is crucial to improve clinical outcome [1], [2], [3], [4], [11], [15].
P. aeruginosa is an important cause of a wide variety
References (23)
- et al.
Surveillance of antibiotic resistance in European ICUs
J. Hosp. Infect.
(2001) - et al.
Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000)
Diagn. Microbiol. Infect. Dis.
(2002) - et al.
Monotherapy versus combination therapy for bacterial infections
Med. Clin. North Am.
(2000) - et al.
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
Clin. Microbiol. Infect.
(2002) - et al.
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam
Int. J. Antimicrob. Agents
(2003) - et al.
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Clin. Microbiol. Rev.
(1996) - et al.
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
Clin. Microbiol. Rev.
(1998) Clinical problems posed by multiresistant nonfermenting Gram-negative pathogens
Clin. Infect. Dis.
(1998)Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria
Clin. Infect. Dis.
(1999)- et al.
Characterisation of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997–1999
Clin. Infect. Dis.
(2001)
Cited by (109)
Frequent Urinary Tract Infection
2018, Physician Assistant ClinicsRecent Epidemiological Changes in Infectious Diseases
2017, Comprehensive Medicinal Chemistry IIIOld antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes
2017, International Journal of Antimicrobial AgentsIntraabdominal abscess caused by Stenotrophomonas maltophilia: A case report
2017, International Journal of Surgery Case ReportsCitation Excerpt :TMP-SMX has been considered the first-line treatment for S. maltophilia infections, based on in vitro susceptibility rates [13,14], rather than clinical studies. Tetracyclines are considered to be second-line agents and fluoroquinolones are alternative options [11,12,15]. However, TMP-SMX-resistant strains have been increasingly reported [16,17] and the TMP-SMX intolerance or allergic reactions are not uncommon.
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan
2016, Journal of Microbiology, Immunology and InfectionCitation Excerpt :These results implied the importance of genospecies differentiation of the A. baumannii complex for clinical treatment guidance. P. aeruginosa was the leading NFGNB that caused nosocomial NFGNB bacteremia.3,20 Increasing prevalence of multidrug resistant P. aeruginosa even worsened the clinical treatment, with increased mortality rate in bacteremic patients.4,8,21–24
Occurrence of Stenotrophomonas maltophilia in agricultural soils and antibiotic resistance properties
2016, Research in Microbiology